Telerehabilitation Using Mirror Therapy in Patients With Phantom Limb Pain Following Lower Limb Amputation.

Sponsor
Zuyd University of Applied Sciences (Other)
Overall Status
Unknown status
CT.gov ID
NCT02076490
Collaborator
Maastricht University (Other)
105
3
19

Study Details

Study Description

Brief Summary

The overall aim of this randomized controlled study is to investigate the effectiveness of mirror therapy supported by telerehabilitation on the intensity, duration and frequency of phantom limb pain and daily activities compared to traditional mirror therapy and sensomotor exercises without a mirror in patients following lower limb amputation.

Condition or Disease Intervention/Treatment Phase
  • Other: Physical/Occupational therapy
N/A

Detailed Description

Up to 75% of patients after amputation of an arm or leg suffer from chronic phantom limb pain that still is perceived in the missing limb, leading to limitations in daily activities and quality of life. The treatment of phantom limb pain is still challenging. Despite many different pharmacological interventions, the outcomes on the longer-term are in many cases not satisfying. Alternative, non-pharmacological interventions, such as mirror therapy, are gaining increased recognition in the treatment of phantom limb pain. In this context, telerehabilitation plays an important role to support long-term self-management and autonomy of these patients.

In the developmental phase of the project, a user-centred design is applied. Patients as well as physical and occupational therapists are interviewed concerning their preferences and needs with respect to the design and content of the telerehabilitation. Additionally, two focus groups with each five participants will be conducted. Subsequently, a prototype of the telerehabilitation will be developed based on user preferences, available evidence, expert opinion and already existing systems. This prototype will be tested on its usability and technical performance in phase three using the thinking-aloud-method and data logging. Accordingly, a multicenter, randomized controlled trial will be conducted to evaluate the cost-effectiveness of the telerehabilitation.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
105 participants
Allocation:
Randomized
Intervention Model:
Factorial Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Health Services Research
Official Title:
The PACT Trial - PAtient Centered Telerehabilitation: Effectiveness of Software-supported and Traditional Mirror Therapy in Patients With Phantom Limb Pain Following Lower Limb Amputation: Design of a Randomized Controlled Trial.
Study Start Date :
May 1, 2014
Anticipated Primary Completion Date :
May 1, 2015
Anticipated Study Completion Date :
Dec 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: Software Supported Mirror Therapy

First experimental condition Physical/Occupational Therapy

Other: Physical/Occupational therapy
At least 10 individual sessions over the clinical intervention period of 4 weeks followed by a 6 weeks self-management phase.

Experimental: Traditional mirror therapy

Second experimental condition Physical/Occupational Therapy

Other: Physical/Occupational therapy
At least 10 individual sessions over the clinical intervention period of 4 weeks followed by a 6 weeks self-management phase.

Active Comparator: Sensomotor exercises without mirror

Control condition Physical/Occupational Therapy

Other: Physical/Occupational therapy
At least 10 individual sessions over the clinical intervention period of 4 weeks followed by a 6 weeks self-management phase.

Outcome Measures

Primary Outcome Measures

  1. Change in average intensity of phantom limb pain [At baseline, 4 and 6 weeks following baseline and at 6 months follow-up]

    Measurement instrument: 11-point NRS

  2. Change in frequency of phantom limb pain [At baseline, 4 and 6 weeks following baseline and at 6 months follow-up]

  3. Change in duration of phantom limb pain [At baseline, 4 and 6 weeks following baseline and at 6 months follow-up]

Secondary Outcome Measures

  1. Change in pain related limitations in daily activities [At baseline, 4 and 6 weeks following baseline and at 6 months follow-up]

    Measurement instrument: PDI, PSFS

  2. Change in pain specific self-efficacy [At baseline, 4 and 6 weeks following baseline and at 6 months follow-up]

    Measurement instrument: Pain specific self-efficacy scale

  3. Change in quality of life [At baseline, 4 and 6 weeks following baseline and at 6 months follow-up]

    Measurement instrument: EQ-5D-5L

  4. Change in global perceived effect [At baseline, 4 and 6 weeks following baseline and at 6 months follow-up]

    Measurement instrument: GPE scale

  5. Change in dimensions of phantom limb pain [At baseline, 4 and 6 weeks following baseline and at 6 months follow-up]

    Measurement instrument: Neuropathic Pain Symptom Inventory (NPSI)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Lower limb amputation

  2. At least since one week constant or intermittent phantom limb pain (PLP) with an average intensity of at least score 3 on the 11-point NRS and a minimum frequency of one episode of PLP per week.

  3. Sufficient cognitive, communicative and motor functions to be able to use the telerehabilitation service, to concentrate for at least 15 minutes on the mirror image and to follow instructions and questionnaires; this is based on clinical judgment of recruiting physicians or therapists.

Exclusion Criteria:
  1. Duration of inpatient rehabilitation not long enough to ensure the 4-week clinical intervention phase.

  2. Bilateral amputation, severe co-morbidity (e.g. stroke) or pain affecting the intact limb; this prevents engagement in the prescribed exercise programs of the study.

  3. Severe psychiatric disorders that preclude patients from participating in the trial.

  4. Intensive course of mirror therapy in the past (> 6 treatments during the last three months).

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Zuyd University of Applied Sciences
  • Maastricht University

Investigators

  • Study Director: Rob J Smeets, Prof., Dr., Research School CAPHRI, Maastricht University, Maastricht, The Netherlands

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Zuyd University of Applied Sciences
ClinicalTrials.gov Identifier:
NCT02076490
Other Study ID Numbers:
  • 005-GW02-035
First Posted:
Mar 3, 2014
Last Update Posted:
Mar 3, 2014
Last Verified:
Feb 1, 2014
Keywords provided by Zuyd University of Applied Sciences
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 3, 2014